|
Real-time
Boerse Muenchen
03:43:46 08/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 19.50 EUR | 0.00% |
|
+0.52% | -53.57% |
| Market Cap | 712M 636M 594M 539M 1.02B 68.91B 1.02B 7.14B 2.79B 35.04B 2.67B 2.62B 113B | P/E 2026 * |
13.2x | P/E 2027 * | 6.57x |
|---|---|---|---|---|---|
| Enterprise Value | 1.56B 1.4B 1.3B 1.18B 2.23B 151B 2.25B 15.66B 6.12B 76.93B 5.87B 5.74B 247B | EV / Sales 2026 * |
1.87x | EV / Sales 2027 * | 1.49x |
| Free-Float |
77.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COLL | Delayed | |
CBOE
| COLL | Real-time | |
|
Boerse Muenchen
| 354 | Real-time | |
|
Tradegate
| 354 | Real-time | |
|
Deutsche Boerse AG
| 354 | Delayed | |
|
Börse Stuttgart
| 354 | Delayed |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 week | +0.52% | ||
| Current month | +0.52% | ||
| 1 month | -4.41% | ||
| 3 months | -40.91% | ||
| 6 months | -30.41% | ||
| Current year | -53.57% |
| 1 week | 19.3 |  | 19.8 |
| 1 month | 18.9 | | 20.4 |
| 3 years | 18.9 | | 42.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.52% | -32.76% | -12.16% | 712M | |
| +2.85% | +2.56% | +40.66% | +107.54% | 1,032B | |
| +1.49% | -2.28% | +36.96% | +63.18% | 614B | |
| +1.82% | +3.58% | +16.38% | +81.72% | 471B | |
| +1.07% | -1.95% | +62.62% | +36.34% | 350B | |
| +2.92% | +3.12% | +24.78% | +43.51% | 337B | |
| +2.42% | +0.05% | +14.13% | +36.19% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.40% | -2.16% | +39.54% | +51.88% | 218B | |
| +1.79% | -1.61% | +25.58% | +95.38% | 179B | |
| Average | +1.82% | -3.39% | +22.32% | +51.58% | 412.76B | |
| Weighted average by Cap. | +2.00% | -3.18% | +31.87% | +69.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 836M 747M 697M 633M 1.19B 80.83B 1.2B 8.37B 3.27B 41.11B 3.14B 3.07B 132B | 847M 756M 706M 641M 1.21B 81.89B 1.22B 8.48B 3.31B 41.65B 3.18B 3.11B 134B |
| Net income | 43.25M 38.65M 36.06M 32.75M 61.68M 4.18B 62.14M 433M 169M 2.13B 162M 159M 6.84B | 89.53M 79.99M 74.63M 67.79M 128M 8.66B 129M 897M 350M 4.4B 336M 329M 14.16B |
| Net Debt | 851M 761M 710M 645M 1.21B 82.36B 1.22B 8.53B 3.33B 41.88B 3.2B 3.13B 135B | 553M 494M 461M 419M 789M 53.5B 795M 5.54B 2.16B 27.21B 2.08B 2.03B 87.47B |
| Date | Price | Change |
|---|---|---|
| 08/10/26 | €19.50 | 0.00% |
| 06/10/26 | €19.50 | 0.00% |
| 05/10/26 | €19.50 | -0.51% |
| 02/10/26 | €19.60 | +0.51% |
| 01/10/26 | €19.50 | +0.52% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
Select your edition
All financial news and data tailored to specific country editions
